MicroRNA Gene Expression Test Classifies Thyroid Nodules
Using the expression levels of 10 miRNAs, the test achieves a negative predictive value of 94% and positive predictive value of 74% at a cancer prevalence of 32%.
Read MorePosted by Elaine Sanchez Wilson | Apr 27, 2015 | Cancer, Molecular Diagnostics |
Using the expression levels of 10 miRNAs, the test achieves a negative predictive value of 94% and positive predictive value of 74% at a cancer prevalence of 32%.
Read MorePosted by Steve Halasey | Apr 20, 2015 | Research |
Studies led by Mayo Clinic investigators combine common genetic variants and other factors to improve personalized estimates of breast cancer risk.
Read MorePosted by Elaine Sanchez Wilson | Apr 7, 2015 | Computing Systems, Information Technology |
In clinical labs, the application of modern lab informatics systems covers a growing range of uses.
Read MorePosted by Elaine Sanchez Wilson | Apr 2, 2015 | Molecular Diagnostics |
CLP spoke with Roger D. Klein, MD, JD, FCAP, medical director for molecular oncology at the Cleveland Clinic, and chair of the Association for Molecular Pathology’s professional relations committee, to find out more about AMP’s revised policy on direct-to-consumer genetic testing.
Read MorePosted by Steve Halasey | Mar 18, 2015 | Cancer, Molecular Diagnostics |
The new partnership will focus on creating a universal test system for clinical trials of targeted cancer therapies, with the goal of developing a more comprehensive tool for precision medicine.
Read More